Page last updated: 2024-08-17

4-nitroquinoline-1-oxide and sirolimus

4-nitroquinoline-1-oxide has been researched along with sirolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amornphimoltham, P; Czerninski, R; Gutkind, JS; Molinolo, AA; Patel, V	1

Other Studies

1 other study(ies) available for 4-nitroquinoline-1-oxide and sirolimus

Article	Year
Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:1 Topics: 4-Nitroquinoline-1-oxide; Animals; Antibiotics, Antineoplastic; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Disease Progression; Female; Gene Expression; Head and Neck Neoplasms; Immunohistochemistry; Mice; Mice, Inbred C57BL; Precancerous Conditions; Protein Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2009

Article

Year

Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.

Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:1

Topics: 4-Nitroquinoline-1-oxide; Animals; Antibiotics, Antineoplastic; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Disease Progression; Female; Gene Expression; Head and Neck Neoplasms; Immunohistochemistry; Mice; Mice, Inbred C57BL; Precancerous Conditions; Protein Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2009